Danish multinational pharmaceutical company Novo Nordisk is the latest player to have evinced interest in India’s Paras Healthcare as the hospital operator looks for capital to expand its operations and pave the way for the exit of its existing backer, Creador.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
